Anticancer efficiencies of the quantitatively minor phenolic components of EVOO polyphenols, traditionally overshadowed by oleic acid, were tested on MCF-7 (HER2-negative), MCF-7/HER2 and HER2 gene-amplified SK-Br3 breast cancer cell lines [70]. This evidence concerns the gene ERBB2 and breast carcinoma.